Journal: Scientific Reports
Article Title: Histological effects of combined therapy involving scar resection, decellularized scaffolds, and human iPSC-NS/PCs transplantation in chronic complete spinal cord injury
doi: 10.1038/s41598-024-82959-7
Figure Lengend Snippet: Therapeutic effects of scar resection and dECM hydrogel (scaffold). ( a ) Experimental design and images of scar resection and dECM hydrogel (scaffold) in the chronic transected SCI model. ( b ) Heatmap of the angiogenesis-associated genes in the scar resection and scar resection + scaffold groups. Scale, 0 < − log 10|adjusted P| < 1.00. ( c ) Examination of neovascularization at the epicenter using immunohistochemical staining for CD31. Scale bar, 1000 μm. ( d ) Quantification of the CD31+ area in the 1000-μm-wide regions at the epicenter (n = 4 each). One-way ANOVA followed by the Tukey–Kramer test; N.S., not significant; *P < 0.05. Data are expressed as mean ± SEM.
Article Snippet: The sections were then processed for histological analysis using the following primary antibodies: anti-HNA (MAB4383, mouse IgG1, 1:100, Millipore, Inc.), anti-GFAP (16825-1-AP, rabbit IgG, 1:500, Proteintech, Inc.; mouse IgG2a, Thermo Fisher, Inc.), anti-CS56 (C8035, rabbit IgG, 1:200, Sigma–Aldrich), anti-Arg1 (ab60176, goat IgG, 1:400, Abcam, Inc.), anti-Iba1 (019-19741, rabbit IgG, 1:1000, Wako), anti-CD31 (AF3628, goat IgG, 1:100, R&D Systems, Inc.), anti-ELAVL3/4 (Hu C/D) (A21271, mouse IgG2b, 1:500, Molecular Probes, Inc.), anti-APC (ab16794, mouse IgG2b, 1:300, Abcam, Inc.), STEM121 (Y40420, mouse IgG1, 1:200, Takara Bio, Inc.), anti-NF-H (rodent-specific) (ab8135, rabbit IgG, 1:500, Abcam, Inc.), and anti-βIII-tubulin (mouse IgG2b, 1:500, Sigma, Inc.).
Techniques: Immunohistochemical staining, Staining